Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01450540 · ClinicalTrials.gov registry record · NA
Automated Graduated CPAP (AGPAP) for Improved Adherence in Newly Diagnosed Obstructive Sleep Apnea (OSA) Patients
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 241
- Enrollment target
NCT01450540: Completed NA study, sponsored by Philips Respironics.
NCT01450540 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 241 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01450540, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 241 participants
- Enrollment target
Study Summary
Although positive airway pressure (PAP) is a highly effective treatment for sleep apnea, adherence to therapy remains an obstacle. Automated Graduated CPAP (AGPAP), also know as EZ-start, is an extended duration ramp, where the patient receives pressure below their prescription during an acclimation phase. The algorithm gradually increases pressure to therapy level based on usage. The aim of this study was to determine the effectiveness of the AGPAP acclimation period and its impact on short term adherence.
Primary Outcome
Device usage (hours per night)
Interventions
- DEVICE REMstar Auto A-Flex
- DEVICE modified REMstar Auto A-Flex with AGPAP
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 241 participants |
| Start Date | 2011-09 |
| Est. Completion | 2013-04 |
| Phase | NA |
What the finished NCT01450540 record still lists
NCT01450540 is an interventional study that assigns participants to a tested intervention. The registered 241 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (83% lower).
The record links to 0 conditions, and to 2 interventions - of which REMstar Auto A-Flex is the first listed.
NCT01450540 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01450540 about?
NCT01450540 is a clinical study titled "Automated Graduated CPAP (AGPAP) for Improved Adherence in Newly Diagnosed Obstructive Sleep Apnea (OSA) Patients". Although positive airway pressure (PAP) is a highly effective treatment for sleep apnea, adherence to therapy remains an obstacle. Automated Graduated CPAP (AGPAP), also know as EZ-start, is an extended duration ramp, where the patient receives pressure below their prescription during an acclimation...
What is the current status of trial NCT01450540?
This trial is currently completed. It is a NA study. The enrollment target is 241 participants. The study started on 2011-09. Estimated completion is 2013-04.
What interventions are being tested in trial NCT01450540?
The interventions under investigation include: REMstar Auto A-Flex (DEVICE), modified REMstar Auto A-Flex with AGPAP (DEVICE).
Who is sponsoring clinical trial NCT01450540?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01450540's enrollment target sits among peer trials
241 440th of 2000 higher than 1,561 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01189786 · 241 participants · NA
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
- NCT05050383 · 241 participants · NA
DISE: Phenotyping Obstruction Patterns
- NCT05683418 · 241 participants · Phase 1
A Study to Evaluate the Safety and Tolerability of TOS-358 in Adults With HR+ Breast Cancer and Other Select Solid Tumors
- NCT07213791 · 241 participants · Phase 1
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia